首页> 外文期刊>PLoS Biology >Chemical Rescue of Malaria Parasites Lacking an Apicoplast Defines Organelle Function in Blood-Stage Plasmodium falciparum
【24h】

Chemical Rescue of Malaria Parasites Lacking an Apicoplast Defines Organelle Function in Blood-Stage Plasmodium falciparum

机译:缺乏顶质体的疟疾寄生虫的化学救援定义了血期恶性疟原虫的细胞器功能

获取原文
           

摘要

Plasmodium spp parasites harbor an unusual plastid organelle called the apicoplast. Due to its prokaryotic origin and essential function, the apicoplast is a key target for development of new anti-malarials. Over 500 proteins are predicted to localize to this organelle and several prokaryotic biochemical pathways have been annotated, yet the essential role of the apicoplast during human infection remains a mystery. Previous work showed that treatment with fosmidomycin, an inhibitor of non-mevalonate isoprenoid precursor biosynthesis in the apicoplast, inhibits the growth of blood-stage P. falciparum. Herein, we demonstrate that fosmidomycin inhibition can be chemically rescued by supplementation with isopentenyl pyrophosphate (IPP), the pathway product. Surprisingly, IPP supplementation also completely reverses death following treatment with antibiotics that cause loss of the apicoplast. We show that antibiotic-treated parasites rescued with IPP over multiple cycles specifically lose their apicoplast genome and fail to process or localize organelle proteins, rendering them functionally apicoplast-minus. Despite the loss of this essential organelle, these apicoplast-minus auxotrophs can be grown indefinitely in asexual blood stage culture but are entirely dependent on exogenous IPP for survival. These findings indicate that isoprenoid precursor biosynthesis is the only essential function of the apicoplast during blood-stage growth. Moreover, apicoplast-minus P. falciparum strains will be a powerful tool for further investigation of apicoplast biology as well as drug and vaccine development.
机译:疟原虫spp寄生虫带有一种不寻常的质体细胞器,称为apicoplast。由于其原核生物的起源和基本功能,因此其是开发新型抗疟疾药物的主要目标。预计将有500多种蛋白质定位于该细胞器,并注释了几种原核生物化学途径,但在人类感染过程中,apicoplast的基本作用仍然是一个谜。先前的研究表明,用磷酰胺霉素(一种非甲羟戊酸类异戊二烯前体生物合成的抑制剂)治疗,能抑制血液中恶性疟原虫的生长。在这里,我们证明可以通过补充途径产物焦磷酸异戊烯酯(IPP)来化学挽救磷霉素的抑制作用。出人意料的是,IPP补充剂还可以完全逆转用导致绒毛膜丧失的抗生素治疗后的死亡。我们表明,用IPP在多个周期内拯救出的抗生素治疗寄生虫会特异性地失去它们的粘质体基因组,并且无法处理或定位细胞器蛋白,从而使它们在功能上变为无粘质体。尽管失去了这种必需的细胞器,但这些无营养的营养体可以在无性血液阶段培养中无限期生长,但是完全依赖于外源IPP来维持生存。这些发现表明,类异戊二烯前体的生物合成是血阶段生长过程中apicoplast的唯一基本功能。此外,无粘液性恶性疟原虫菌株将是进一步研究粘质体生物学以及药物和疫苗开发的有力工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号